Smooth muscle cell-derived adenosine inhibits cell growth

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 766-773

  Dubey, Raghvendra K ^a   Gillespie, Delbert G ^a   Mi, Zaichuan ^a   Suzuki, Fumio ^b   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

adenosine; atherosclerosis; hyperplasia; muscle, smooth, vascular; neointima

Indexed keywords

8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; DIPYRIDAMOLE;

ANIMAL EXPERIMENT; AORTA; ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; HYPERPLASIA; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029984283     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.766     Document Type: Conference Paper

References (44)

1. Bobik A, Campbell JH. Vascular derived growth factors: cell biology, pathophysiology and pharmacology. Pharmacol Rev. 1993; 45:1-42.
2. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension. 1992;20:713-736.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
4. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
5. Luscher TF, Dubey RK. Endothelium and platelet-derived vasoactive substances: role in the regulation of vascular tone and growth. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York, NY: Raven Press Publishers; 1995:609-629.
6. Gibbons GH. Autocrine-paracrine factors and vascular remodeling in hypertension. Curr Opin Nephrol Hypertens. 1993;2:291-298.
7. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991;18(suppl III):III-115-III-121.
8. Anfossi G, Cavalot F, Massucco P, Mattielo L, Mularoni E, Hahn A, Trovati M. Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. Metab Clin Exp. 1993;42: 1081-1083.
9. Lindner V, Giachelli CM, Schwartz SM, Reidy MA. A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res. 1995;76:951-957.
10. Dubey RK, Mi Z, Jackson EK. Vascular smooth muscle cells metabolize cyclic-AMP to generate adenosine. Hypertension. 1995,26:576. Abstract.
11. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86: 1690-1697.
12. Nilsson J, Olsson AG. Prostaglandin E inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Atherosclerosis. 1984;54:77-82.
13. 1 receptors. J Clin Invest. 1995;96: 141-149.
14. Headrick JP, Berne RM. Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am J Physiol. 1990;259: H62-H67.
15. Cristalli G, Vittori S, Thompson RD, Padgett WL, Shi D, Daly JW, Olsson RA. Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1994; 349:644-650.
16. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 1994;76:5-13.
17. Yen MH, Wu CC, Chiou WF. Partially endothelium-dependent vasodilator effect of adenosine in rat aorta. Hypertension. 1988;11: 514-518.
18. Vials A, Burnstock G. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol. 1993;109:424-429.
19. De Mey J, Burnstock G, Vanhoutte PM. Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur J Pharmacol. 1979;55: 401-405.
20. Ekas RD Jr, Steenberg ML, Eikenburg DC, Lokhandwala MF. Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur J Pharmacol. 1981;76:301-307.
21. Jackson EK. Adenosine: a physiological brake on renin release. Annu Rev Pharmacol Toxicol. 1991;31:1-35.
22. Murray RD, Churchill PC. Effects of adenosine receptor agonists in the isolated, perfused rat kidney. Am J Physiol. 1984;247: H343-H348.
23. 2b receptor. Hypertension. 1996;27:786-793.
24. Jackson EK, Koehler M, Mi Z, Dubey RK, Tofovic SP, Carcillo JA, Jones GS. Possible role of adenosine deaminase in vasoocclusive diseases. J Hypertens. In press.
25. Schrader J. Formation and metabolism of adenosine and adenine nucleotides in cardiac tissue. In: Phillis JW, ed. Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Boca Raton, Fla: CRC Press; 1991:55-69.
26. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J. 1986;233:309-319.
27. Lloyd HG, Deussen A, Wuppermann H, Schrader J. The transmethylation pathway as a source for adenosine in the isolated guinea-pig heart. Biochem J. 1988;252:489-494.
28. Mi Z, Jackson EK. Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exp Ther. 1995;273:728-733.
29. Dalziel HH, Westfall DP. Receptors for adenine nucleotides and nucleosides: sub classification, distribution, and molecular characterization. Pharmacol Rev. 1994;46:449-466.
30. Norton ED, Jackson EK, Turner MB, Vinmani R, Forman MB. The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury. Am Heart J. 1992;123:332-338.
31. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation. 1992;85:659-665.
32. Auchampach JA, Gross GJ. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol. 1993; 264:H1327-H1336.
33. Yao Z, Gross GJ. Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned myocardium. Circulation. 1993;88:235-244.
34. Geiger JD, Padua RA, Nagy JI. Adenosine deaminase regulation of purine actions. In: Phillis JW, ed. Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Boca Raton, Fla: CRC Press; 1991:71-84.
35. Fredholm BB, Sollevi A. The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline. J Physiol (Lond). 1981;313:351-367.
36. German DC, Kredich NM, Bjornsson TD. Oral dipyridamole increases plasma adenosine levels in human beings. Clin Pharmacol Ther. 1989;45:80-84.
37. Wang T, Mentzer RM, Van Wylen DGC. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol. 1992;263:H552-H558.
38. Conti JB, Blelardinelli L, Utterback DB, Curtis AB. Endogenous adenosine is an antiarrhythmic agent. Circulation. 1995;91:1761-1767.
39. Mills I, Gewirtz H. Cultured vascular smooth muscle cells from porcine coronary artery possess A1 and A2 adenosine receptor activity. Biochem Biophys Res Commun. 1990;168:1297-1302.
40. Jonzon B, Nilsson J, Fredholm BB. Adenosine receptor-mediated changes in cyclic AMP production and DNA synthesis in cultured arterial smooth muscle cells. J Cell Physiol. 1985;124:451-456.
41. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells: mitogenic responses to angiotensin II. Circ Res. 1992;71:1143-1152.
42. 2 antagonists. J Med Chem. 1992;35:2342-2345.
43. DeMey JGR, Dijkstra EH, Vrijdag MJJF. Endothelium reduces DNA synthesis in isolated arteries. Am J Physiol. 1991;260: H1128-H1134.
44. Smolenski RT, Kochan ZK, McDouall R, Page C, Seymour A-ML, Yacoub MH. Endothelial nucleotide catabolism and adenosine production. Cardiovasc Res. 1994;28:100-104.